Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Vorapaxar: History, Applications & Products

Vorapaxar (brand name Zontivity, formerly known as SCH 530348) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine, discovered by Schering-Plough and developed by Merck & Co.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Vorapaxar topic overview

The analysis highlights History, Applications and Products as prominent areas in the source structure around Vorapaxar.

Related topics
48
Source areas
7
Connected nodes
55
Extracted relationships
46
Related term clusters
21
Bridge connections
55

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Drug interactions · 19 topics
Contraindications · 8 topics
History · 8 topics
Overview · 6 topics
Mechanism of action · 3 topics
Dose adjustment · 2 topics
Medical uses · 2 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol)
Interactive image
ATC code
B01AC26 (WHO)
Bioavailability
~100%
CAS Number
618385-01-6 Y
ChEBI
CHEBI:82702 N
ChEMBL
ChEMBL493982 N

Start with your topic. Discover where to go next.

Explore different angles and find fresh ideas to shape your next piece of content.

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Medical uses

Contraindications

Drug interactions

Dose adjustment

Mechanism of action

History

For the semantics nerds

You can skip this section if you’re here for content ideas and keyword inspiration.

Advanced semantic analysis

How Vorapaxar connects Entity context

The extracted context around Vorapaxar shows recurring relationship patterns in the source. For example, Vorapaxar → ADP, Among, FDA, February, In January, January, May, Merck, PAD, The TRA, TIMI Another extracted example is Vorapaxar → CYP3A, CYP3A4, John's, St. Use these groups to spot repeated connection types before inspecting the individual relationships.

Vorapaxar

Top relations

related to history · 11
Vorapaxar → ADP, Among, FDA, February, In January, January, May, Merck, PAD, The TRA, TIMI
related to Drug interactions · 4
Vorapaxar → CYP3A, CYP3A4, John's, St
related to Mechanism of action · 3
Vorapaxar → ADP-mediated, P2Y12, PAR-1
Legal status · 2
Vorapaxar → CA: ℞-only, US: ℞-only
related to Medical uses · 2
Vorapaxar → MI, Studies
3D model (JSmol) · 1
Vorapaxar → Interactive image
ATC code · 1
Vorapaxar → B01AC26 (WHO)
Bioavailability · 1
Vorapaxar → ~100%
CAS Number · 1
Vorapaxar → 618385-01-6 Y
ChEBI · 1
Vorapaxar → CHEBI:82702 N

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

stroke risk bleeding history heart attack patients coronary death cyp3a4 antagonist persons cardiovascular intracranial par-1 revascularization drug dose adjustment hepatic

Vorapaxar relationships Subject–Predicate–Object triples

TTTA extracted 46 structured relationships around Vorapaxar. Examples in this analysis include Vorapaxar → 3D model (JSmol) → Interactive image and Vorapaxar → ATC code → B01AC26 (WHO). The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
Vorapaxar3D model (JSmol)Interactive image1.00infobox
VorapaxarATC codeB01AC26 (WHO)1.00infobox
VorapaxarBioavailability~100%1.00infobox
VorapaxarCAS Number618385-01-6 Y1.00infobox
VorapaxarChEBICHEBI:82702 N1.00infobox
VorapaxarChEMBLChEMBL493982 N1.00infobox
VorapaxarChemSpider8252668 N1.00infobox
VorapaxarCompTox Dashboard (EPA)DTXSID2010093361.00infobox
VorapaxarECHA InfoCard100.116.7671.00infobox
VorapaxarElimination half-life5–13 days1.00infobox
VorapaxarExcretionfeces (58%), urine (25%)1.00infobox
VorapaxarFormulaC29H33FN2O41.00infobox
VorapaxarIUPHAR/BPS40471.00infobox
VorapaxarLegal statusCA: ℞-only1.00infobox
VorapaxarLegal statusUS: ℞-only1.00infobox
VorapaxarMelting point278 °C (532 °F)1.00infobox
VorapaxarMetabolismhepatic (CYP3A4 and CYP2J2)1.00infobox
VorapaxarMolar mass492.591 g·mol−11.00infobox
VorapaxarOther namesSCH-5303481.00infobox
VorapaxarProtein binding≥99%1.00infobox
VorapaxarPubChem CID100771301.00infobox
VorapaxarRoutes of administrationBy mouth1.00infobox
VorapaxarTrade namesZontivity1.00infobox
VorapaxarUNIIZCE93644N21.00infobox

Related concept clusters Related term clusters

The concept neighborhoods around Vorapaxar bring nearby vocabulary together. In this analysis, examples include Attack, Stroke and Heart. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Vorapaxar
    • Attack
    • Stroke
    • Heart
    • Antagonist
    • History
    • Patients
    • Risk
    • Half-life
    • Metabolism
    • Point
    • Zontivity
    • Antiplatelet
  • vorapaxar
    • Attack
    • Stroke
    • Heart
    • Antagonist
    • History
    • Patients
    • Risk
    • Half-life
    • Metabolism
    • Point
    • Zontivity
    • Antiplatelet
  • transient ischemic attack
    • Heart
    • History
    • Stroke
    • Patients
    • Vorapaxar
    • Disease
    • Drug
    • Study
    • Cardiovascular
    • Death
    • Risk
    • Half-life
  • peripheral arterial disease
    • History
    • Heart
    • Patients
    • Half-life
    • Mechanism
    • Metabolism
    • Name
    • Point
    • Zontivity
    • Dose
    • Drug
    • Hepatic
  • vascular disease
    • History
    • Heart
    • Patients
    • Half-life
    • Mechanism
    • Metabolism
    • Name
    • Point
    • Zontivity
    • Dose
    • Drug
    • Hepatic
  • history
    • Hemorrhage
    • Intracranial
    • Heart
    • Patients
    • Risk
    • Half-life
    • Mechanism
    • Metabolism
    • Name
    • Point
    • Stroke
    • Vorapaxar
  • drug interactions
    • Attack
    • Heart
    • Half-life
    • Mechanism
    • Metabolism
    • Name
    • Point
    • Zontivity
    • Antiplatelet
    • Cyp3a4
    • Disease
    • Hepatic
  • receptor antagonist
    • Par-1
    • Merck
    • Name
    • Zontivity
    • Antiplatelet
    • Drug
    • Placebo
    • Revascularization
    • Study
    • Urgent
    • Vorapaxar
    • Cardiovascular

Connections between topic areas Semantic bridges

For Vorapaxar, one of the stronger structural bridges in this analysis connects Vorapaxar with Drug interactions. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Vorapaxar — Drug interactions · splits 36 ⟂ 20
Vorapaxar — Contraindications · splits 47 ⟂ 9
Vorapaxar — History · splits 47 ⟂ 9
Vorapaxar — Overview · splits 49 ⟂ 7
Vorapaxar — Mechanism of action · splits 52 ⟂ 4
Vorapaxar — Medical uses · splits 53 ⟂ 3
Vorapaxar — Dose adjustment · splits 53 ⟂ 3

Map overview Semantic statistics

Vorapaxar

Nodes56
Edges55
Triples46
Avg. degree1.96
Density0.035714
Components1

Source & methodology

TTTA analyzes the structure around Vorapaxar to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications & Products, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Vorapaxar · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.

Monitor your Domain Rating with FrogDR